Phillips-Medisize, a Molex company, announced the release of its third generation connected health platform, a service offering for its pharma and drug delivery device clients. The platform builds on the success of the company’s first connected health solutions, including the first FDA-approved co…

Phillips-Medisize, a Molex company, has announced the completion of another significant expansion to the company’s New Richmond, Wisconsin medical facility. With this expansion, the New Richmond site will bring value-added capabilities in drug handling to serve its pharmaceutical customers with th…

Phillips-Medisize, a Molex company, announces the expansion of a significant medical customer for the Molex Little Rock facility. The long-time customer is a leader in consumable diagnostics cancer testing, with its take-home diagnostic kit for cancer detection.

This is an exciting expansion for both…

Phillips-Medisize, a Molex company, announces its initial investment to expand the capabilities of the 380,000 square foot Molex Little Rock facility to include a FDA registered manufacturing Center of Excellence for Connected Health and drug delivery devices.

The construction of purpose-built clean…

Phillips-Medisize, a Molex company, will participate at the 14th Parental Drug Association (PDA) Universe of Pre-filled Syringes and Injection Devices Conference and Exhibition in the Austria Center in Vienna on 7-8 November 2017. Phillips-Medisize has a stand (X68/69) in the exhibition area at the…

Phillips-Medisize, a Molex company, will be exhibiting at K39 in hall 8a during COMPAMED 2017. COMPAMED takes place simultaneously with the Medica exhibition on November 13-16 in Düsseldorf. Come visit the booth to see the expanded and integrated Phillips-Medisize and Molex capabilities.

Phillips-Medi…

Phillips-Medisize Corporation receives the 2017 Metal Powder Industries Federation (MPIF) grand prize award in the automotive engine category at this year's POWDERMET show.

Phillips-Medisize, along with its customer Delphi, received the award for its metal injection molded (MIM) four- slot fuel valve…

Phillips-Medisize congratulates ivWatch, LLC on their recent recognition as a finalist in Medical Design Excellence Awards (MDEA). ivWatch LLC is a nominee for the Model 400 device in the Nonsurgical Hospital Supplies and Equipment category. Winners will be announced on June 13, in New York, during…

Phillips-Medisize, a Molex company, announced today the appointment of Michael Ratigan to Vice President of Global Sales. With the company’s continued growth in biopharma drug delivery devices, consumable diagnostics, and medical devices, this is the latest in a series of strategic hires.

“Mike’s…

Phillips-Medisize’s stand 1E28 at Medtec Europe, Stuttgart/Germany, April 4th to 6th, 2017, is designed for medical device professionals to discuss future products – from the first idea through to engineered-in scalability and batch production respectively. Several display cases reveal a clear v…